SLDB compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

SLDBSolid Biosciences Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

SLDBSolid Biosciences Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SLDB

1 of 4at or beyond implied

Reportimpliedrealized× implied

Mar 9 '26±75.6%▲+18.81%×0.25

Nov 4 '25±38.3%▼−15.29%×0.40

Feb 18 '25±29.3%▲+31.51%×1.08

Jan 8 '24±15.0%▲+7.59%×0.51

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 4 '26±3.7%▲+3.73%×1.00

Aug 5 '26±4.1%▲+4.57%×1.12

= impliedSLDB realized, solidAMGN realized, hatchedOne scale, both sides: full bar = 76%× = |realized| ÷ impliedspan: SLDB 791d · AMGN 273dSource: market data

May 1 '26

±3.9%

▼−4.75%

×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

SLDBSolid Biosciences Inc.

6.57▲+6.31%· post 6.57

Mkt cap$735.5MRevenue—Revenue—

AMGNAmgen Inc

460.55▲+0.06%· post 460.42

ClosedNov 6 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

ClosedNov 6 '26

SLDBSolid Biosciences Inc.

AMGNAmgen Inc

6.57▲+6.31%post 6.57

Price

460.55▲+0.06%post 460.42

$735.5M

Mkt cap

$249.0B

—

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

SLDB6.57▲+6.31%vsAMGN460.55▲+0.06%ClosedNov 6 '26